glp 1 reduce inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits GLP-1 drugs calm inflammation beyond
Description
We observed a delayed rise in BrAC and subjective effects in the GLP-1RA group as compared to controls, that was not explained by nausea
No need to swallow capsulesjust stick on a patch and go
Best For: Clients beginning their weight loss journey
But among patients who stopped it, two-thirds regained most of their weight within a year
Sources for Figure 218
Recent signals underscore this shift: Eli Lilly became the first pharmaceutical company to surpass a $1 trillion market capitalization [1] buoyed by global demand for obesity medications
